
Global Ophthalmology And Vision Science Congress
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Ophthalmology And Vision Science Congress — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Global Ophthalmology & Vision Science Congress (GOVIS 2027)
Dates: June 14–16, 2027
Venue: Rome, Italy and Online (Hybrid Event)
The Global Ophthalmology and Vision Science Congress (GOVIS 2027) is an international, hybrid congress dedicated to advancing eye health, visual sciences, and clinical ophthalmology through collaboration, research exchange, and innovation. Held in Rome, Italy with comprehensive online participation, GOVIS 2027 is designed to connect a global community of clinicians, researchers, and industry representatives who share a common goal: improving vision care outcomes worldwide.
Set under the theme “From Insight to Foresight in Ophthalmology”, the congress brings together ophthalmologists, optometrists, vision researchers, eye-care professionals, technologists, and industry representatives to explore the newest scientific findings and emerging approaches across the full spectrum of ophthalmology.
The scientific program includes keynote lectures, scientific sessions, panel discussions, symposia, hands-on workshops, and clinical case presentations. Content spans major subspecialties of ophthalmology and vision science, with programming intended to support both professional development and meaningful knowledge transfer between research discovery and clinical practice.
Participants can engage with leading experts, connect with international peers, and review state-of-the-art advances in both clinical care and technology-driven innovation. In addition, the congress offers opportunities for research visibility and professional networking, while also welcoming students, early-career professionals, and emerging researchers to present work, gain recognition, and strengthen mentorship and collaboration pathways.
GOVIS 2027 places special emphasis on forward-looking topics and cutting-edge directions in the field, including:
- Digital ophthalmology
- AI-assisted diagnostics
- Gene and cell therapies
- Regenerative techniques
- Advanced surgical innovations
Scientific topics are organized around both foundational and applied areas of vision science and ophthalmic practice, including:
- Core and Foundational Vision Sciences
- Molecular, Genetic and Regenerative Ophthalmology
- Visual Neuroscience and Brain-Eye Integration
- Clinical Ophthalmology and Subspecialties
- Analytical, Imaging and Diagnostic Sciences
- Ocular Pharmacology, Therapeutics and Drug Delivery
- Ophthalmic Surgery and Techniques
- Ophthalmic Devices and Surgical Innovations
Whether attending onsite in Rome or participating online, delegates can expect a high-quality scientific experience with interactive discussions, collaboration opportunities, and engagement with industry partners showcasing relevant advancements and technologies. For attendees seeking to stay current with the latest developments in ophthalmology and vision science, GOVIS 2027 also includes CPD accreditation, offering 15+ CPD credits to support ongoing professional learning.
Join GOVIS 2027 to contribute to shaping the future of eye health and vision science—by turning today’s insights into tomorrow’s clinical foresight.
Data sheet
| Event Name | Global Ophthalmology & Vision Science Congress (GOVIS 2027) |
| Event Date | June 14–16, 2027 |
| Event Status | Upcoming |
| Venue | Rome, Italy and Online (official website). User-supplied venue/location details were not used because they conflict with the official event site. |
| City | Rome |
| State / Region | Lazio |
| Country | Italy |
| Organizer | Not clearly stated in the provided official website text |
| Official Event Website | globalophthalmologycongress.com |
| Event Type | Hybrid international scientific congress / conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Global scientific and clinical audience with onsite and virtual participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to medium; official site confirms format and dates but does not publish a verified attendance count in the provided text. |
| Main Purpose of Event | To share advances in ophthalmology and vision science, support clinical and research collaboration, showcase technologies, and connect eye-care professionals with industry partners. |
Global Ophthalmology & Vision Science Congress (GOVIS 2027) is an international hybrid congress focused on eye health, clinical ophthalmology, and vision science. The official program highlights keynote lectures, scientific sessions, panel discussions, symposia, workshops, and clinical case presentations across major subspecialties including retina, glaucoma, cataract, cornea, pediatrics, imaging, neuro-ophthalmology, and ocular oncology.
The event matters because it brings together clinicians, researchers, technologists, and industry representatives in a setting that supports scientific exchange, product awareness, professional education, and partnership development. It is especially relevant for suppliers of ophthalmic devices, imaging systems, diagnostics, surgical tools, digital health solutions, therapeutics, and research-enabling technologies.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Ophthalmology clinicians | Hospitals, eye institutes, specialty clinics, academic medical centers | Influence on product selection, clinical adoption, and formulary or device evaluation | High-value audience for surgical, diagnostic, imaging, and therapeutic offerings |
| Vision researchers | Universities, research institutes, translational labs | Research specification, trial design, grant-funded purchasing influence | Relevant for imaging platforms, assays, analytics, and research tools |
| Optometrists and vision care professionals | Optometry networks, clinics, retail eye-care chains | Recommenders and evaluators of diagnostic and patient-care solutions | Useful for screening, refraction, imaging, and patient engagement tools |
| Hospital procurement and sourcing teams | Hospitals, health systems, ambulatory surgical centers | Vendor screening, RFPs, sourcing, contract negotiations | Important for capital equipment, consumables, and service contracts |
| Biomedical / clinical engineering teams | Hospitals, device evaluation centers, academic systems | Technical due diligence, integration, maintenance, and lifecycle oversight | High relevance for equipment vendors and software providers |
| Industry representatives / commercial teams | Medical device manufacturers, pharma, diagnostics companies | Business development, partnership, channel, and scientific collaboration | Potential buyers, partners, and event-facing decision-makers |
| Digital health / AI leaders | Healthcare technology firms, ophthalmic AI vendors, tele-ophthalmology platforms | Solution evaluation, product strategy, integration decisions | Strong fit for software, imaging analytics, AI, and workflow tools |
| Students, residents, fellows, and early-career professionals | Medical schools, training hospitals, academic programs | Influence and future purchasing relevance; high engagement for education-focused vendors | Useful for education, simulation, and professional development offerings |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Rome | Local hospitals, universities, clinics, and medical device stakeholders | Medium | Onsite participation likely supplemented by online attendees |
| Host region: Lazio / central Italy | Regional clinicians, researchers, and suppliers | Medium | Convenient access for Italian ophthalmology networks |
| National Italy reach | Medical schools, eye centers, health systems, distributors | High | Strong domestic relevance for clinical and commercial participants |
| European Union and EMEA | Ophthalmology groups, medtech firms, distributors, research institutions | High | Rome is attractive for European scientific travel and collaboration |
| Global online audience | International clinicians, researchers, and commercial attendees | High | Hybrid format broadens reach beyond travel-limited participants |
| North America, Middle East, Asia-Pacific | Specialty clinics, academic centers, distributors, and device companies | Medium to high | Likely remote participation driven by scientific and commercial interest |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website describes an international hybrid congress with worldwide accessibility, scientific exchange, and broad participation across ophthalmology and vision science. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Not publicly verified | N/A | Current-year attendee/exhibitor list was not provided in the official text. | N/A | N/A | Attendance Not Confirmed |
| University eye research centers | Research institution | Likely attendee profile for scientific exchange, imaging, and translational research | harvard.edu | Director of Research, Principal Investigator, Clinical Research Manager | Strong Market Fit, Attendance Not Confirmed |
| Hospital eye departments | Healthcare provider | Primary clinical users of ophthalmic devices and diagnostic tools | massgeneral.org | Department Chair, Ophthalmology Director, Service Line Director | Strong Market Fit, Attendance Not Confirmed |
| Specialty eye hospitals | Healthcare provider | High relevance for surgical innovation, imaging, and patient-care solutions | moorfields.nhs.uk | Clinical Director, Procurement Lead, Operating Theatre Manager | Strong Market Fit, Attendance Not Confirmed |
| National health systems | Public healthcare buyer | Potential buyer of ophthalmic equipment, software, and services | nhs.uk | Procurement Manager, Clinical Purchasing Manager, Head of Ophthalmology | Strong Market Fit, Attendance Not Confirmed |
| Medical device manufacturers | Commercial buyer / partner | Likely commercial attendee segment for partnership, clinical education, and market intelligence | alcon.com | Product Manager, Business Development Director, Regional Sales Director | Strong Market Fit, Attendance Not Confirmed |
| Ophthalmic diagnostics companies | Technology supplier / buyer | Relevant for imaging, screening, and diagnostic workflow discussions | topconhealthcare.com | VP Marketing, Director of Product, Clinical Applications Manager | Strong Market Fit, Attendance Not Confirmed |
| Surgical equipment companies | Medtech supplier / buyer | Potential users and exhibitors for surgical innovations and workflow technology | zeiss.com | Surgical Sales Director, Product Specialist, Strategic Accounts Manager | Strong Market Fit, Attendance Not Confirmed |
| Pharmaceutical companies | Life sciences buyer / partner | Relevant for therapeutics, trials, and clinical collaboration | novartis.com | Medical Affairs Director, Clinical Program Manager, Partnering Lead | Strong Market Fit, Attendance Not Confirmed |
| University medical centers | Academic healthcare buyer | Often drive adoption of new clinical protocols and research instrumentation | stanford.edu | Chief Medical Officer, Research Director, Capital Equipment Manager | Strong Market Fit, Attendance Not Confirmed |
| Clinical trial networks | Research / trial buyer | Useful for R&D collaboration and patient recruitment technology | ciscrp.org | Clinical Operations Director, Trial Manager, Program Director | Strong Market Fit, Attendance Not Confirmed |
| National ophthalmology associations | Association / professional body | Potential attendee, sponsor, and referral network | aao.org | Executive Director, Education Lead, Conference Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Distributors of eye-care products | Distributor | Channel buyers for diagnostic and surgical portfolios | essilorluxottica.com | Distributor Principal, Category Manager, Commercial Director | Strong Market Fit, Attendance Not Confirmed |
| Tele-ophthalmology / health IT vendors | Software and services buyer | Relevant for digital ophthalmology, AI, and remote care workflows | siemens-healthineers.com | IT Director, Digital Health Lead, Product Strategy Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Medical Director | Clinical Leadership | C-Level / VP | Influences clinical adoption, strategic partnerships, and hospital technology priorities |
| 2 | Head of Ophthalmology / Ophthalmology Chair | Clinical | Director / Chair | Key decision-maker for devices, procedures, and clinical workflow modernization |
| 3 | Director of Procurement / Procurement Manager | Procurement | Manager / Director | Controls sourcing, vendor shortlists, and contract decisions |
| 4 | Director of Clinical Research / Principal Investigator | Research | Director / Senior Researcher | Drives evaluation of tools, data capture, and trial-related technologies |
| 5 | Biomedical Engineering Director | Clinical Engineering | Director / Manager | Evaluates technical compatibility, service needs, and lifecycle costs |
| 6 | Product Manager / Director of Product | Product | Manager / Director | Commercial and clinical product direction for medtech or software |
| 7 | Business Development Director / Partnerships Director | Commercial | Director / VP | Important for collaboration, licensing, and channel development |
| 8 | Clinical Applications Manager / Specialist | Customer Success / Clinical Support | Manager / Specialist | Supports training, adoption, and implementation of products |
| 9 | IT Director / Digital Health Lead | Information Technology | Director / Head | Relevant for AI, imaging platforms, telehealth, and data integration |
| 10 | Operations Director / Service Line Director | Operations | Director / VP | Influences equipment rollout, process improvement, and patient flow |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core end-user base for ophthalmology services, devices, and clinical workflows | Hospitals, eye centers, ambulatory surgery centers |
| 2 | Medical Devices | Highly relevant for diagnostic and surgical equipment suppliers and buyers | Device selection, product launches, strategic accounts |
| 3 | Pharmaceuticals | Relevant for ophthalmic therapeutics, clinical trials, and medical affairs | Therapies, pipeline partnerships, investigator outreach |
| 4 | Biotechnology | Supports gene therapy, regenerative medicine, and translational science topics | R&D collaboration, clinical trial and innovation buyers |
| 5 | Information Technology & Services | Digital ophthalmology, AI, imaging, and interoperability are major themes | Software, workflow automation, clinical data platforms |
| 6 | Computer Software | Relevant for AI-assisted diagnostics, telehealth, and practice management | Imaging analytics, patient engagement, SaaS solutions |
| 7 | Research | Strong scientific conference participation base | Academic collaboration, lab tools, clinical research support |
| 8 | Higher Education | Universities often send faculty, researchers, and trainees | Education tech, training, and research partnerships |
| 9 | Government Administration | Public healthcare systems and procurement bodies may attend online or onsite | Procurement, public tenders, health program adoption |
| 10 | International Trade & Development | Useful for global access, distribution, and cross-border collaboration | International channels, market expansion, distributor partnerships |
| 11 | Biotechnology | Also relevant for biologics, gene therapy, and regenerative techniques discussed | Research collaboration and pipeline partnerships |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Official website text provided | No verified attendance count in the supplied official content |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official website text provided | The provided text mentions industry partners but does not state a count |
| Buyer count | Not publicly confirmed | Unconfirmed | Official website text provided | Scientific congress; buyer presence inferred from participant mix, not quantified |
| Speaker count | Not publicly confirmed | Unconfirmed | Official website text provided | Speakers section exists, but the supplied text does not provide a count |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official website text provided | No sponsor list or sponsor count included in the supplied text |
| Historical attendance | Prior-year figures not supplied | Unavailable | No prior-year official list in provided source text | Use current official materials or organizer media kit if available |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical ophthalmology | Better diagnostics, treatment precision, and workflow efficiency | Demonstrations, case studies, evidence-based product discussions | Imaging, surgical systems, consumables, clinical software |
| AI-assisted diagnostics | Automated screening and decision support | Pilot projects, partnerships with clinicians, workflow proof points | AI analytics, diagnostic software, computer vision tools |
| Surgical innovation | Safer, faster, more accurate procedures | Hands-on workshops and surgeon education | Surgical devices, instruments, visualization systems |
| Retinal and glaucoma care | Advanced diagnostic and monitoring capabilities | Clinical proof, KOL engagement, specialty positioning | Retinal imaging, OCT, monitoring platforms |
| Gene and cell therapy | Research collaboration and translational pathways | Scientific sessions, investigator networking, partnership discussions | Biotech platforms, trial services, advanced research tools |
| Digital ophthalmology | Telemedicine, remote triage, workflow digitization | Interoperability and implementation conversations | Telehealth platforms, EHR add-ons, cloud software |
| Medical education and training | CPD credits, skill development, mentorship | Education sponsorships, training content, product education | Simulation, e-learning, webinars, content services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience includes clinicians, researchers, procurement teams, and industry stakeholders directly connected to ophthalmology purchasing decisions. |
| Decision-maker availability | High | Likely to include directors, heads of department, medical leaders, product leaders, and partnership executives. |
| Data collection potential | Medium | Current official text confirms strong program themes but does not provide a verified attendee list in the supplied material. |
| Apollo targeting potential | Very High | Excellent fit for Hospital & Health Care, Medical Devices, Pharmaceuticals, Biotechnology, and IT/Services targeting. |
| Geographic targeting potential | High | Rome plus global virtual participation creates strong Europe, EMEA, and worldwide targeting potential. |
| Best outreach approach | High-touch, clinical-value-led | Use clinical outcomes, product education, and partnership-based messaging rather than generic event promotion. |
| Overall lead quality | High | Strong relevance for attendee list building, supplier prospecting, and medtech/pharma outreach. |
| Best use case | B2B attendee list sales, exhibitor targeting, KOL mapping, and buyer profiling | Especially valuable for companies selling ophthalmic devices, diagnostics, software, therapeutics, and research tools. |
| Limitations / risks | Verified attendee data is limited | Without a public participant list, outreach should rely on role-based prospecting and official speaker/committee updates where available. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Information Technology & Services; Computer Software; Research; Higher Education; Government Administration; International Trade & Development | Prioritize the most relevant buyer and partner organizations around ophthalmology, research, and digital health. |
| Departments | Procurement; Clinical; Research; Product; Engineering; IT; Operations; Business Development; Partnerships; Medical Affairs | Capture both buying centers and commercial/clinical stakeholders. |
| Seniority | Manager; Director; VP; CXO; Head; Owner; Partner | Focus on decision-makers and strong influencers. |
| Job titles | Head of Ophthalmology, Ophthalmology Director, Procurement Manager, Clinical Research Director, Medical Director, Product Manager, Business Development Director, Digital Health Lead, IT Director, Clinical Applications Manager | Targets core buyer and influencer roles most likely to engage with event-relevant solutions. |
| Geography | Italy; Western Europe; EMEA; United Kingdom; Germany; France; Spain; Netherlands; United States; Canada; Gulf Cooperation Council; India | Align with the hybrid international audience and global ophthalmology market. |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,000+ | Covers clinics, hospitals, medtech firms, and global life sciences organizations. |
| Keywords | ophthalmology, vision science, retina, glaucoma, cataract, cornea, ocular imaging, OCT, tele-ophthalmology, eye care, surgical innovation, digital ophthalmology, AI diagnostics, clinical research | Sharpen search results for event-specific and solution-specific targeting. |
| Company type | Healthcare provider; Public company; Private company; Research institution; Government agency; Association | Supports mixed buyer, user, and partner targeting. |
| Revenue range | When relevant: $1M–$10M, $10M–$50M, $50M–$100M, $100M+ | Useful for separating smaller clinics from enterprise medtech and healthcare systems. |
| Funding / public company filters | Public company; recently funded; venture-backed; growth stage | Helpful for medtech, biotech, and software vendors seeking active market spenders. |
| Technologies | EHR, telehealth, PACS, imaging software, cloud, AI/ML, clinical trial platforms | Useful for technology vendors targeting digital transformation in eye care. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Global Ophthalmology & Vision Science Congress official website | Official organizer / event site | Verified event name, hybrid format, dates, venue city/country, agenda themes, and scientific focus areas | High |
| Official website text supplied by user | Primary source excerpt | Confirmed GOVIS 2027 title, June 14–16, 2027 dates, Rome/online venue, and scientific scope | High |
| Venue / location details from the prompt | User-provided event metadata | Cross-checked against official website text; official site takes precedence where conflicts exist | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Global Ophthalmology And Vision Science Congress — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.